Humco Holding Group, Inc

FDA Regulatory Profile

Humco Holding Group, Inc appears in FDA public data with 5 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0022-2019, Class II) was initiated on August 28, 2018.

Summary

Total Recalls
5
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0022-2019Class IIThyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active PharmaceuticalAugust 28, 2018
D-0024-2019Class IIThyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active PharmaAugust 28, 2018
D-0023-2019Class IIThyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active PharmaceuticalAugust 28, 2018
D-1048-2014Class IIMercuroclear Antiseptic Anesthetic First Aid Helps prevent infection and relieves pain and itching oNovember 26, 2013
D-197-2013Class IIMercuroclear Antiseptic Anesthetic First Aid Helps prevent infection and relieves pain and itching oJanuary 17, 2013